nodes	percent_of_prediction	percent_of_DWPC	metapath
Midazolam—Stridor—Riluzole—amyotrophic lateral sclerosis	0.0224	0.0562	CcSEcCtD
Midazolam—Hypoventilation—Riluzole—amyotrophic lateral sclerosis	0.0196	0.0491	CcSEcCtD
Midazolam—Yawning—Riluzole—amyotrophic lateral sclerosis	0.0181	0.0455	CcSEcCtD
Midazolam—GABRR3—peripheral nervous system—amyotrophic lateral sclerosis	0.0179	0.0601	CbGeAlD
Midazolam—GABRR2—peripheral nervous system—amyotrophic lateral sclerosis	0.0155	0.0521	CbGeAlD
Midazolam—GABRR1—peripheral nervous system—amyotrophic lateral sclerosis	0.015	0.0501	CbGeAlD
Midazolam—GABRQ—nerve—amyotrophic lateral sclerosis	0.014	0.0468	CbGeAlD
Midazolam—GABRR3—nerve—amyotrophic lateral sclerosis	0.014	0.0468	CbGeAlD
Midazolam—Hostility—Riluzole—amyotrophic lateral sclerosis	0.0132	0.0331	CcSEcCtD
Midazolam—GABRR2—nerve—amyotrophic lateral sclerosis	0.0121	0.0406	CbGeAlD
Midazolam—GABRR1—nerve—amyotrophic lateral sclerosis	0.0117	0.0391	CbGeAlD
Midazolam—Hypoxia—Riluzole—amyotrophic lateral sclerosis	0.0115	0.0288	CcSEcCtD
Midazolam—Hyperventilation—Riluzole—amyotrophic lateral sclerosis	0.0106	0.0266	CcSEcCtD
Midazolam—Thrombosis—Riluzole—amyotrophic lateral sclerosis	0.0103	0.0259	CcSEcCtD
Midazolam—Delusion—Riluzole—amyotrophic lateral sclerosis	0.0103	0.0259	CcSEcCtD
Midazolam—Pulmonary function test decreased—Riluzole—amyotrophic lateral sclerosis	0.00968	0.0243	CcSEcCtD
Midazolam—Respiratory depression—Riluzole—amyotrophic lateral sclerosis	0.00968	0.0243	CcSEcCtD
Midazolam—Apnoea—Riluzole—amyotrophic lateral sclerosis	0.0086	0.0216	CcSEcCtD
Midazolam—Delirium—Riluzole—amyotrophic lateral sclerosis	0.00848	0.0213	CcSEcCtD
Midazolam—Musculoskeletal stiffness—Riluzole—amyotrophic lateral sclerosis	0.00813	0.0204	CcSEcCtD
Midazolam—Ventricular extrasystoles—Riluzole—amyotrophic lateral sclerosis	0.00807	0.0203	CcSEcCtD
Midazolam—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.00771	0.0194	CcSEcCtD
Midazolam—Respiratory failure—Riluzole—amyotrophic lateral sclerosis	0.00742	0.0186	CcSEcCtD
Midazolam—Hiccups—Riluzole—amyotrophic lateral sclerosis	0.00729	0.0183	CcSEcCtD
Midazolam—Ventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00729	0.0183	CcSEcCtD
Midazolam—GABRA6—hindbrain—amyotrophic lateral sclerosis	0.00726	0.0244	CbGeAlD
Midazolam—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00704	0.0177	CcSEcCtD
Midazolam—Mazindol—SIGMAR1—amyotrophic lateral sclerosis	0.00696	0.555	CrCbGaD
Midazolam—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.00626	0.0157	CcSEcCtD
Midazolam—Phlebitis—Riluzole—amyotrophic lateral sclerosis	0.00614	0.0154	CcSEcCtD
Midazolam—Injury—Riluzole—amyotrophic lateral sclerosis	0.00576	0.0145	CcSEcCtD
Midazolam—Clobazam—SLC6A1—amyotrophic lateral sclerosis	0.00558	0.445	CrCbGaD
Midazolam—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00547	0.0137	CcSEcCtD
Midazolam—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.00542	0.0136	CcSEcCtD
Midazolam—GABRB2—hindbrain—amyotrophic lateral sclerosis	0.00535	0.0179	CbGeAlD
Midazolam—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00529	0.0133	CcSEcCtD
Midazolam—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00529	0.0133	CcSEcCtD
Midazolam—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.00521	0.0131	CcSEcCtD
Midazolam—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00517	0.013	CcSEcCtD
Midazolam—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.00503	0.0126	CcSEcCtD
Midazolam—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.00501	0.0126	CcSEcCtD
Midazolam—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00498	0.0125	CcSEcCtD
Midazolam—GABRA2—hindbrain—amyotrophic lateral sclerosis	0.00488	0.0164	CbGeAlD
Midazolam—GABRA1—hindbrain—amyotrophic lateral sclerosis	0.00472	0.0158	CbGeAlD
Midazolam—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00467	0.0117	CcSEcCtD
Midazolam—GABRA6—brainstem—amyotrophic lateral sclerosis	0.00416	0.014	CbGeAlD
Midazolam—Depression—Riluzole—amyotrophic lateral sclerosis	0.00407	0.0102	CcSEcCtD
Midazolam—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.004	0.01	CcSEcCtD
Midazolam—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00373	0.00936	CcSEcCtD
Midazolam—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00364	0.00915	CcSEcCtD
Midazolam—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.0036	0.00904	CcSEcCtD
Midazolam—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00342	0.00859	CcSEcCtD
Midazolam—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.0034	0.00853	CcSEcCtD
Midazolam—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00331	0.0083	CcSEcCtD
Midazolam—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.0033	0.00829	CcSEcCtD
Midazolam—Chills—Riluzole—amyotrophic lateral sclerosis	0.00328	0.00825	CcSEcCtD
Midazolam—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00321	0.00806	CcSEcCtD
Midazolam—CYP4B1—cerebellum—amyotrophic lateral sclerosis	0.00318	0.0107	CbGeAlD
Midazolam—GABRQ—nervous system—amyotrophic lateral sclerosis	0.00314	0.0105	CbGeAlD
Midazolam—GABRR3—nervous system—amyotrophic lateral sclerosis	0.00314	0.0105	CbGeAlD
Midazolam—Tension—Riluzole—amyotrophic lateral sclerosis	0.00313	0.00785	CcSEcCtD
Midazolam—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.0031	0.00777	CcSEcCtD
Midazolam—GABRB2—brainstem—amyotrophic lateral sclerosis	0.00306	0.0103	CbGeAlD
Midazolam—GABRD—medulla oblongata—amyotrophic lateral sclerosis	0.00303	0.0102	CbGeAlD
Midazolam—GABRQ—central nervous system—amyotrophic lateral sclerosis	0.00302	0.0101	CbGeAlD
Midazolam—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00299	0.0075	CcSEcCtD
Midazolam—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00293	0.00736	CcSEcCtD
Midazolam—GABRG1—medulla oblongata—amyotrophic lateral sclerosis	0.00292	0.00979	CbGeAlD
Midazolam—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00286	0.00719	CcSEcCtD
Midazolam—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00286	0.00718	CcSEcCtD
Midazolam—GABRB1—medulla oblongata—amyotrophic lateral sclerosis	0.00283	0.00949	CbGeAlD
Midazolam—GABRA2—brainstem—amyotrophic lateral sclerosis	0.0028	0.00939	CbGeAlD
Midazolam—Cough—Riluzole—amyotrophic lateral sclerosis	0.00278	0.00698	CcSEcCtD
Midazolam—GABRG3—nervous system—amyotrophic lateral sclerosis	0.00275	0.00923	CbGeAlD
Midazolam—GABRR2—nervous system—amyotrophic lateral sclerosis	0.00272	0.00913	CbGeAlD
Midazolam—GABRA1—brainstem—amyotrophic lateral sclerosis	0.00271	0.00907	CbGeAlD
Midazolam—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.0027	0.00679	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00269	0.00677	CcSEcCtD
Midazolam—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00265	0.00666	CcSEcCtD
Midazolam—GABRG3—central nervous system—amyotrophic lateral sclerosis	0.00265	0.00888	CbGeAlD
Midazolam—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00262	0.00659	CcSEcCtD
Midazolam—GABRR1—nervous system—amyotrophic lateral sclerosis	0.00262	0.00879	CbGeAlD
Midazolam—GABRG1—spinal cord—amyotrophic lateral sclerosis	0.0026	0.00873	CbGeAlD
Midazolam—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.0026	0.00653	CcSEcCtD
Midazolam—CYP4B1—brain—amyotrophic lateral sclerosis	0.00259	0.00867	CbGeAlD
Midazolam—GABRR2—cerebellum—amyotrophic lateral sclerosis	0.00256	0.0086	CbGeAlD
Midazolam—Shock—Riluzole—amyotrophic lateral sclerosis	0.00256	0.00643	CcSEcCtD
Midazolam—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00255	0.00641	CcSEcCtD
Midazolam—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00254	0.00638	CcSEcCtD
Midazolam—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00253	0.00634	CcSEcCtD
Midazolam—GABRR1—central nervous system—amyotrophic lateral sclerosis	0.00252	0.00847	CbGeAlD
Midazolam—GABRB1—spinal cord—amyotrophic lateral sclerosis	0.00252	0.00846	CbGeAlD
Midazolam—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00243	0.0061	CcSEcCtD
Midazolam—GABRQ—brain—amyotrophic lateral sclerosis	0.0024	0.00805	CbGeAlD
Midazolam—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00234	0.00587	CcSEcCtD
Midazolam—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00232	0.00582	CcSEcCtD
Midazolam—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00231	0.00581	CcSEcCtD
Midazolam—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00229	0.00575	CcSEcCtD
Midazolam—GABRD—nervous system—amyotrophic lateral sclerosis	0.00228	0.00764	CbGeAlD
Midazolam—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00225	0.00564	CcSEcCtD
Midazolam—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00224	0.00563	CcSEcCtD
Midazolam—Pain—Riluzole—amyotrophic lateral sclerosis	0.00222	0.00559	CcSEcCtD
Midazolam—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00222	0.00559	CcSEcCtD
Midazolam—GABRD—central nervous system—amyotrophic lateral sclerosis	0.00219	0.00736	CbGeAlD
Midazolam—GABRG1—nervous system—amyotrophic lateral sclerosis	0.00219	0.00736	CbGeAlD
Midazolam—GABRA6—nervous system—amyotrophic lateral sclerosis	0.00218	0.00731	CbGeAlD
Midazolam—GABRD—cerebellum—amyotrophic lateral sclerosis	0.00214	0.00719	CbGeAlD
Midazolam—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00214	0.00538	CcSEcCtD
Midazolam—GABRG2—medulla oblongata—amyotrophic lateral sclerosis	0.00214	0.00717	CbGeAlD
Midazolam—GABRB2—medulla oblongata—amyotrophic lateral sclerosis	0.00214	0.00717	CbGeAlD
Midazolam—GABRB1—nervous system—amyotrophic lateral sclerosis	0.00213	0.00713	CbGeAlD
Midazolam—GABRA5—nervous system—amyotrophic lateral sclerosis	0.00212	0.00709	CbGeAlD
Midazolam—GABRG1—central nervous system—amyotrophic lateral sclerosis	0.00211	0.00708	CbGeAlD
Midazolam—GABRG3—brain—amyotrophic lateral sclerosis	0.0021	0.00705	CbGeAlD
Midazolam—GABRA6—central nervous system—amyotrophic lateral sclerosis	0.0021	0.00704	CbGeAlD
Midazolam—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00207	0.00519	CcSEcCtD
Midazolam—GABRG1—cerebellum—amyotrophic lateral sclerosis	0.00206	0.00692	CbGeAlD
Midazolam—GABRA6—cerebellum—amyotrophic lateral sclerosis	0.00205	0.00688	CbGeAlD
Midazolam—GABRB1—central nervous system—amyotrophic lateral sclerosis	0.00205	0.00687	CbGeAlD
Midazolam—GABRA5—central nervous system—amyotrophic lateral sclerosis	0.00204	0.00683	CbGeAlD
Midazolam—GABRR1—brain—amyotrophic lateral sclerosis	0.002	0.00672	CbGeAlD
Midazolam—GABRB1—cerebellum—amyotrophic lateral sclerosis	0.002	0.00671	CbGeAlD
Midazolam—GABRA3—nervous system—amyotrophic lateral sclerosis	0.00197	0.0066	CbGeAlD
Midazolam—GABRA4—nervous system—amyotrophic lateral sclerosis	0.00192	0.00644	CbGeAlD
Midazolam—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00192	0.00481	CcSEcCtD
Midazolam—GABRB2—spinal cord—amyotrophic lateral sclerosis	0.00191	0.00639	CbGeAlD
Midazolam—GABRG2—spinal cord—amyotrophic lateral sclerosis	0.00191	0.00639	CbGeAlD
Midazolam—GABRA3—central nervous system—amyotrophic lateral sclerosis	0.0019	0.00636	CbGeAlD
Midazolam—GABRA1—medulla oblongata—amyotrophic lateral sclerosis	0.00189	0.00633	CbGeAlD
Midazolam—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00187	0.00469	CcSEcCtD
Midazolam—GABRA4—central nervous system—amyotrophic lateral sclerosis	0.00185	0.0062	CbGeAlD
Midazolam—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00184	0.00462	CcSEcCtD
Midazolam—GABRA4—cerebellum—amyotrophic lateral sclerosis	0.00181	0.00606	CbGeAlD
Midazolam—GABRD—brain—amyotrophic lateral sclerosis	0.00174	0.00584	CbGeAlD
Midazolam—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00172	0.00432	CcSEcCtD
Midazolam—GABRA1—spinal cord—amyotrophic lateral sclerosis	0.00168	0.00564	CbGeAlD
Midazolam—GABRG1—brain—amyotrophic lateral sclerosis	0.00168	0.00562	CbGeAlD
Midazolam—GABRA6—brain—amyotrophic lateral sclerosis	0.00167	0.00559	CbGeAlD
Midazolam—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00165	0.00415	CcSEcCtD
Midazolam—GABRB3—medulla oblongata—amyotrophic lateral sclerosis	0.00164	0.0055	CbGeAlD
Midazolam—Rash—Riluzole—amyotrophic lateral sclerosis	0.00164	0.00412	CcSEcCtD
Midazolam—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00164	0.00411	CcSEcCtD
Midazolam—Headache—Riluzole—amyotrophic lateral sclerosis	0.00163	0.00409	CcSEcCtD
Midazolam—GABRB1—brain—amyotrophic lateral sclerosis	0.00163	0.00545	CbGeAlD
Midazolam—GABRA5—brain—amyotrophic lateral sclerosis	0.00162	0.00542	CbGeAlD
Midazolam—GABRB2—nervous system—amyotrophic lateral sclerosis	0.00161	0.00538	CbGeAlD
Midazolam—GABRG2—nervous system—amyotrophic lateral sclerosis	0.00161	0.00538	CbGeAlD
Midazolam—GABRG2—central nervous system—amyotrophic lateral sclerosis	0.00155	0.00518	CbGeAlD
Midazolam—GABRB2—central nervous system—amyotrophic lateral sclerosis	0.00155	0.00518	CbGeAlD
Midazolam—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00154	0.00388	CcSEcCtD
Midazolam—GABRB2—cerebellum—amyotrophic lateral sclerosis	0.00151	0.00507	CbGeAlD
Midazolam—GABRG2—cerebellum—amyotrophic lateral sclerosis	0.00151	0.00507	CbGeAlD
Midazolam—GABRA3—brain—amyotrophic lateral sclerosis	0.00151	0.00505	CbGeAlD
Midazolam—GABRA4—brain—amyotrophic lateral sclerosis	0.00147	0.00492	CbGeAlD
Midazolam—GABRA2—nervous system—amyotrophic lateral sclerosis	0.00147	0.00492	CbGeAlD
Midazolam—GABRB3—spinal cord—amyotrophic lateral sclerosis	0.00146	0.00491	CbGeAlD
Midazolam—GABRE—nervous system—amyotrophic lateral sclerosis	0.00145	0.00488	CbGeAlD
Midazolam—GABRA1—nervous system—amyotrophic lateral sclerosis	0.00142	0.00475	CbGeAlD
Midazolam—GABRA2—central nervous system—amyotrophic lateral sclerosis	0.00141	0.00474	CbGeAlD
Midazolam—GABRE—central nervous system—amyotrophic lateral sclerosis	0.0014	0.0047	CbGeAlD
Midazolam—SLC22A1—nervous system—amyotrophic lateral sclerosis	0.00138	0.00464	CbGeAlD
Midazolam—GABRA2—cerebellum—amyotrophic lateral sclerosis	0.00138	0.00463	CbGeAlD
Midazolam—GABRA1—central nervous system—amyotrophic lateral sclerosis	0.00136	0.00458	CbGeAlD
Midazolam—GABRA1—cerebellum—amyotrophic lateral sclerosis	0.00133	0.00447	CbGeAlD
Midazolam—SLC22A1—central nervous system—amyotrophic lateral sclerosis	0.00133	0.00447	CbGeAlD
Midazolam—GABRB3—nervous system—amyotrophic lateral sclerosis	0.00123	0.00413	CbGeAlD
Midazolam—GABRB2—brain—amyotrophic lateral sclerosis	0.00123	0.00412	CbGeAlD
Midazolam—GABRG2—brain—amyotrophic lateral sclerosis	0.00123	0.00412	CbGeAlD
Midazolam—GABRB3—central nervous system—amyotrophic lateral sclerosis	0.00119	0.00398	CbGeAlD
Midazolam—GABRB3—cerebellum—amyotrophic lateral sclerosis	0.00116	0.00389	CbGeAlD
Midazolam—GABRA2—brain—amyotrophic lateral sclerosis	0.00112	0.00376	CbGeAlD
Midazolam—GABRE—brain—amyotrophic lateral sclerosis	0.00111	0.00373	CbGeAlD
Midazolam—GABRA1—brain—amyotrophic lateral sclerosis	0.00108	0.00363	CbGeAlD
Midazolam—SLC22A1—brain—amyotrophic lateral sclerosis	0.00106	0.00355	CbGeAlD
Midazolam—CYP2E1—medulla oblongata—amyotrophic lateral sclerosis	0.00104	0.0035	CbGeAlD
Midazolam—GABRB3—brain—amyotrophic lateral sclerosis	0.000942	0.00316	CbGeAlD
Midazolam—CYP2E1—spinal cord—amyotrophic lateral sclerosis	0.000931	0.00312	CbGeAlD
Midazolam—ABCB1—embryo—amyotrophic lateral sclerosis	0.00093	0.00312	CbGeAlD
Midazolam—CYP2B6—nervous system—amyotrophic lateral sclerosis	0.000836	0.0028	CbGeAlD
Midazolam—CYP2B6—central nervous system—amyotrophic lateral sclerosis	0.000805	0.0027	CbGeAlD
Midazolam—CYP2E1—nervous system—amyotrophic lateral sclerosis	0.000784	0.00263	CbGeAlD
Midazolam—CYP2E1—central nervous system—amyotrophic lateral sclerosis	0.000755	0.00253	CbGeAlD
Midazolam—CYP2E1—cerebellum—amyotrophic lateral sclerosis	0.000738	0.00248	CbGeAlD
Midazolam—CYP2B6—brain—amyotrophic lateral sclerosis	0.000639	0.00214	CbGeAlD
Midazolam—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000631	0.00212	CbGeAlD
Midazolam—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000608	0.00204	CbGeAlD
Midazolam—CYP2E1—brain—amyotrophic lateral sclerosis	0.0006	0.00201	CbGeAlD
Midazolam—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.000595	0.00199	CbGeAlD
Midazolam—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.00053	0.00178	CbGeAlD
Midazolam—ABCB1—nervous system—amyotrophic lateral sclerosis	0.000447	0.0015	CbGeAlD
Midazolam—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.00043	0.00144	CbGeAlD
Midazolam—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.00042	0.00141	CbGeAlD
Midazolam—CYP3A5—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000379	0.0013	CbGpPWpGaD
Midazolam—GABRA2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000378	0.0013	CbGpPWpGaD
Midazolam—GABRA2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000378	0.0013	CbGpPWpGaD
Midazolam—GABRA3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000377	0.0013	CbGpPWpGaD
Midazolam—GABRB3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000375	0.00129	CbGpPWpGaD
Midazolam—GABRB3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000375	0.00129	CbGpPWpGaD
Midazolam—GABRA1—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000375	0.00129	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000372	0.00128	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000372	0.00128	CbGpPWpGaD
Midazolam—GABRA2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000371	0.00127	CbGpPWpGaD
Midazolam—GABRG2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000368	0.00127	CbGpPWpGaD
Midazolam—GABRG2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000368	0.00127	CbGpPWpGaD
Midazolam—GABRB3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000368	0.00126	CbGpPWpGaD
Midazolam—GABRQ—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000367	0.00126	CbGpPWpGaD
Midazolam—GABRR2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000367	0.00126	CbGpPWpGaD
Midazolam—SLC22A1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000364	0.00125	CbGpPWpGaD
Midazolam—GABRG2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000362	0.00124	CbGpPWpGaD
Midazolam—SLC22A1—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00036	0.00124	CbGpPWpGaD
Midazolam—SLC22A1—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00036	0.00124	CbGpPWpGaD
Midazolam—GABRB2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000359	0.00123	CbGpPWpGaD
Midazolam—GABRA5—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000349	0.0012	CbGpPWpGaD
Midazolam—GABRA1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000346	0.00119	CbGpPWpGaD
Midazolam—SLC22A1—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000343	0.00118	CbGpPWpGaD
Midazolam—GABRA3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000343	0.00118	CbGpPWpGaD
Midazolam—ABCB1—brain—amyotrophic lateral sclerosis	0.000341	0.00115	CbGeAlD
Midazolam—UGT1A4—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00034	0.00117	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.000339	0.00117	CbGpPWpGaD
Midazolam—GABRA2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000337	0.00116	CbGpPWpGaD
Midazolam—SLC22A1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000336	0.00115	CbGpPWpGaD
Midazolam—GABRB3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000334	0.00115	CbGpPWpGaD
Midazolam—GABRB3—BDNF signaling pathway—BDNF—amyotrophic lateral sclerosis	0.000329	0.00113	CbGpPWpGaD
Midazolam—GABRG2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000328	0.00113	CbGpPWpGaD
Midazolam—GABRR1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000328	0.00113	CbGpPWpGaD
Midazolam—GABRR1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000328	0.00113	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000326	0.00112	CbGpPWpGaD
Midazolam—SLC22A1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000324	0.00111	CbGpPWpGaD
Midazolam—GABRA1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000322	0.00111	CbGpPWpGaD
Midazolam—GABRA1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000322	0.00111	CbGpPWpGaD
Midazolam—SLC22A1—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000321	0.0011	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000316	0.00109	CbGpPWpGaD
Midazolam—GABRA1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000316	0.00109	CbGpPWpGaD
Midazolam—GABRQ—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000312	0.00107	CbGpPWpGaD
Midazolam—GABRR2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000312	0.00107	CbGpPWpGaD
Midazolam—GABRQ—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000312	0.00107	CbGpPWpGaD
Midazolam—GABRR2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000312	0.00107	CbGpPWpGaD
Midazolam—GABRG3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000303	0.00104	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000301	0.00103	CbGpPWpGaD
Midazolam—GABRB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000298	0.00102	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000297	0.00102	CbGpPWpGaD
Midazolam—SLC22A1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000296	0.00102	CbGpPWpGaD
Midazolam—GABRR1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000292	0.001	CbGpPWpGaD
Midazolam—SLC22A1—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000292	0.001	CbGpPWpGaD
Midazolam—GABRA1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000287	0.000986	CbGpPWpGaD
Midazolam—GABRA6—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000282	0.000969	CbGpPWpGaD
Midazolam—GABRQ—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000278	0.000957	CbGpPWpGaD
Midazolam—GABRA4—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000278	0.000957	CbGpPWpGaD
Midazolam—GABRR2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000278	0.000957	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.000277	0.00095	CbGpPWpGaD
Midazolam—SLC22A1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000276	0.000947	CbGpPWpGaD
Midazolam—SLC22A1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000276	0.000947	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000274	0.00094	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—CASP9—amyotrophic lateral sclerosis	0.000272	0.000934	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00027	0.000929	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—DAO—amyotrophic lateral sclerosis	0.000269	0.000923	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000265	0.000911	CbGpPWpGaD
Midazolam—SLC22A1—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00026	0.000893	CbGpPWpGaD
Midazolam—GABRG3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000257	0.000884	CbGpPWpGaD
Midazolam—GABRG3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000257	0.000884	CbGpPWpGaD
Midazolam—GABRB2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000255	0.000875	CbGpPWpGaD
Midazolam—GABRB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000253	0.000871	CbGpPWpGaD
Midazolam—GABRB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000253	0.000871	CbGpPWpGaD
Midazolam—GABRA5—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000247	0.00085	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000247	0.000848	CbGpPWpGaD
Midazolam—SLC22A1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000246	0.000844	CbGpPWpGaD
Midazolam—GABRA3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000243	0.000835	CbGpPWpGaD
Midazolam—GABRA6—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00024	0.000824	CbGpPWpGaD
Midazolam—GABRA6—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00024	0.000824	CbGpPWpGaD
Midazolam—GABRA2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000239	0.00082	CbGpPWpGaD
Midazolam—GABRB3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000237	0.000815	CbGpPWpGaD
Midazolam—GABRA4—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000237	0.000813	CbGpPWpGaD
Midazolam—GABRA4—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000237	0.000813	CbGpPWpGaD
Midazolam—CYP3A7—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000234	0.000805	CbGpPWpGaD
Midazolam—GABRG2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000233	0.0008	CbGpPWpGaD
Midazolam—CYP3A7—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000231	0.000794	CbGpPWpGaD
Midazolam—GABRG3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000229	0.000788	CbGpPWpGaD
Midazolam—GABRB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000226	0.000776	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000225	0.000773	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—CD40LG—amyotrophic lateral sclerosis	0.000219	0.000752	CbGpPWpGaD
Midazolam—GABRB2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000217	0.000744	CbGpPWpGaD
Midazolam—GABRB2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000217	0.000744	CbGpPWpGaD
Midazolam—GABRA6—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000214	0.000734	CbGpPWpGaD
Midazolam—GABRA4—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000211	0.000725	CbGpPWpGaD
Midazolam—GABRA5—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00021	0.000723	CbGpPWpGaD
Midazolam—GABRA5—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00021	0.000723	CbGpPWpGaD
Midazolam—GABRA3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000207	0.00071	CbGpPWpGaD
Midazolam—GABRA3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000207	0.00071	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000204	0.0007	CbGpPWpGaD
Midazolam—GABRA1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000204	0.000699	CbGpPWpGaD
Midazolam—GABRA2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000203	0.000697	CbGpPWpGaD
Midazolam—GABRA2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000203	0.000697	CbGpPWpGaD
Midazolam—GABRB3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000202	0.000693	CbGpPWpGaD
Midazolam—GABRB3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000202	0.000693	CbGpPWpGaD
Midazolam—GABRG2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000198	0.00068	CbGpPWpGaD
Midazolam—GABRG2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000198	0.00068	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—C3—amyotrophic lateral sclerosis	0.000193	0.000665	CbGpPWpGaD
Midazolam—GABRB2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000193	0.000663	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.00019	0.000654	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—GSR—amyotrophic lateral sclerosis	0.000188	0.000646	CbGpPWpGaD
Midazolam—GABRA5—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000188	0.000644	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000185	0.000634	CbGpPWpGaD
Midazolam—GABRA3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000184	0.000633	CbGpPWpGaD
Midazolam—GABRA2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000181	0.000622	CbGpPWpGaD
Midazolam—GABRB3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00018	0.000618	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00018	0.000617	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00018	0.000617	CbGpPWpGaD
Midazolam—GABRG2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000177	0.000606	CbGpPWpGaD
Midazolam—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000176	0.000605	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000174	0.000599	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.000174	0.000597	CbGpPWpGaD
Midazolam—CYP2B6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000173	0.000595	CbGpPWpGaD
Midazolam—GABRA1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000173	0.000595	CbGpPWpGaD
Midazolam—GABRA1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000173	0.000595	CbGpPWpGaD
Midazolam—CYP2B6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000171	0.000587	CbGpPWpGaD
Midazolam—CYP2E1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.00017	0.000583	CbGpPWpGaD
Midazolam—CYP3A5—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000169	0.000582	CbGpPWpGaD
Midazolam—CYP2E1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000167	0.000575	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000167	0.000574	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000167	0.000574	CbGpPWpGaD
Midazolam—CYP3A5—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000167	0.000574	CbGpPWpGaD
Midazolam—GABRB3—BDNF signaling pathway—CASP3—amyotrophic lateral sclerosis	0.000165	0.000565	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000164	0.000564	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000158	0.000544	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000154	0.00053	CbGpPWpGaD
Midazolam—GABRA1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000154	0.00053	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000154	0.00053	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000153	0.000525	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000153	0.000524	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000148	0.000509	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000148	0.000509	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000144	0.000493	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000142	0.000488	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000134	0.000461	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000134	0.000459	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000133	0.000456	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000133	0.000456	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000133	0.000456	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000133	0.000455	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000132	0.000454	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00013	0.000447	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00013	0.000447	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—DAO—amyotrophic lateral sclerosis	0.00013	0.000446	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00013	0.000446	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00013	0.000446	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000122	0.000419	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000121	0.000417	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000121	0.000415	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000119	0.000409	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000119	0.000408	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	0.000115	0.000393	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000113	0.000389	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000113	0.000388	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000112	0.000386	CbGpPWpGaD
Midazolam—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	0.000112	0.000386	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000111	0.00038	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00011	0.000379	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000108	0.000371	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000106	0.000365	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000104	0.000357	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000104	0.000356	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000102	0.000351	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—APOE—amyotrophic lateral sclerosis	0.0001	0.000344	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PLB1—amyotrophic lateral sclerosis	9.84e-05	0.000338	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	9.8e-05	0.000336	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	9.8e-05	0.000336	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	9.72e-05	0.000334	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—DAO—amyotrophic lateral sclerosis	9.6e-05	0.00033	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—DAO—amyotrophic lateral sclerosis	9.4e-05	0.000323	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—DAO—amyotrophic lateral sclerosis	9.38e-05	0.000322	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PLB1—amyotrophic lateral sclerosis	9.16e-05	0.000315	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—GSR—amyotrophic lateral sclerosis	9.08e-05	0.000312	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	8.96e-05	0.000308	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	8.68e-05	0.000298	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	8.68e-05	0.000298	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—GSR—amyotrophic lateral sclerosis	8.45e-05	0.00029	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	8.33e-05	0.000286	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.3e-05	0.000285	CbGpPWpGaD
Midazolam—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	7.88e-05	0.000271	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	7.83e-05	0.000269	CbGpPWpGaD
Midazolam—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	7.77e-05	0.000267	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	7.74e-05	0.000266	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.62e-05	0.000262	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—CHAT—amyotrophic lateral sclerosis	7.46e-05	0.000256	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	7.34e-05	0.000252	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PLB1—amyotrophic lateral sclerosis	7.28e-05	0.00025	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PLB1—amyotrophic lateral sclerosis	7.13e-05	0.000245	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PLB1—amyotrophic lateral sclerosis	7.11e-05	0.000244	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	7.08e-05	0.000243	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CHAT—amyotrophic lateral sclerosis	6.94e-05	0.000238	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.87e-05	0.000236	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GSR—amyotrophic lateral sclerosis	6.72e-05	0.000231	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GSR—amyotrophic lateral sclerosis	6.58e-05	0.000226	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GSR—amyotrophic lateral sclerosis	6.56e-05	0.000225	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—APOE—amyotrophic lateral sclerosis	6.27e-05	0.000215	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	6.09e-05	0.000209	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	6.03e-05	0.000207	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	6.03e-05	0.000207	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	5.65e-05	0.000194	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	5.52e-05	0.00019	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CHAT—amyotrophic lateral sclerosis	5.51e-05	0.000189	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CHAT—amyotrophic lateral sclerosis	5.4e-05	0.000186	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CHAT—amyotrophic lateral sclerosis	5.39e-05	0.000185	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	5.37e-05	0.000184	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.13e-05	0.000176	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	4.95e-05	0.00017	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	4.82e-05	0.000166	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	4.8e-05	0.000165	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	4.36e-05	0.00015	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.3e-05	0.000148	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	4.07e-05	0.00014	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.01e-05	0.000138	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.73e-05	0.000128	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.68e-05	0.000127	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	3.62e-05	0.000125	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.43e-05	0.000118	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	3.31e-05	0.000114	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	3.05e-05	0.000105	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—APOE—amyotrophic lateral sclerosis	3.03e-05	0.000104	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.96e-05	0.000102	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.9e-05	9.97e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.9e-05	9.95e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—APOE—amyotrophic lateral sclerosis	2.82e-05	9.69e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.72e-05	9.36e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.67e-05	9.16e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.66e-05	9.14e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	2.51e-05	8.61e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—APOE—amyotrophic lateral sclerosis	2.24e-05	7.7e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—APOE—amyotrophic lateral sclerosis	2.19e-05	7.54e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—APOE—amyotrophic lateral sclerosis	2.19e-05	7.52e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.19e-05	7.51e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.08e-05	7.13e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.01e-05	6.9e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.93e-05	6.64e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	1.65e-05	5.68e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.54e-05	5.27e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.5e-05	5.17e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.5e-05	5.16e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.35e-05	4.63e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.24e-05	4.25e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.13e-05	3.89e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	1.02e-05	3.5e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.98e-06	2.4e-05	CbGpPWpGaD
